骨形成蛋白6(BMP6)重組蛋白
Recombinant Bone Morphogenetic Protein 6 (BMP6)
VGR; VGR1; Vegetal Related Growth Factor(TGFB-Related); VG-1-related protein
- 編號(hào)RPA646Mu01
- 物種Mus musculus (Mouse，小鼠)相同的名稱(chēng)，不同的物種。
- 來(lái)源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位分泌
- 預(yù)測(cè)分子量15.6kDa
- 實(shí)際分子量16kDa(差異分析請(qǐng)參閱說(shuō)明書(shū))
- 片段與標(biāo)簽Gln379~Ala506 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)8.2
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見(jiàn)活性蛋白。 - 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1200¥ 3000¥ 6000¥ 18000¥ 45000
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure . Gene Sequencing (extract)
Figure. SDS-PAGE
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA646Mu02 | 骨形成蛋白6(BMP6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA646Mu01 | 骨形成蛋白6(BMP6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA646Mu01 | 骨形成蛋白6(BMP6)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA646Mu02 | 骨形成蛋白6(BMP6)多克隆抗體 | WB; IHC; ICC; IP. |
| SEA646Mu | 骨形成蛋白6(BMP6)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA646Mu | 骨形成蛋白6(BMP6)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| International Journal of Cardiology | Valvular osteoclasts in calcification and aortic valve stenosis severity[PubMed: 23452891] |
| Polskie Archiwum Medycyny Wewn Trznej | New parameters in iron metabolism and functional iron deficiency in patients on maintenance hemodialysis[PubMed: 23111696] |
| PLoS ONE | A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches[Plosone: Source] |
| journal of biomedical materials research part b-applied biomaterials | In vitro chondrogenesis by BMP6 gene therapy[Pubmed: 23077084] |
| Journal of Clinical Pathology | Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C[PubMed: 26290259] |
| Clinical?and Experimental Pharmacology and Physiology | Bone morphogenetic protein 6—a possible new player in pathophysiology of heart failure[pubmed:27592865] |
| International Journal of Biological Macromolecules | SEQUENTIAL IGF-1 AND BMP-6 RELEASING CHITOSAN/ALGINATE/PLGA HYBRID SCAFFOLDS FOR PERIODONTAL REGENERATION[pubmed:28601648] |
| Elife | The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium[Pubmed:29749927] |